Systematic review of the comparative effectiveness of antiepileptic drugs for fibromyalgia.

Summary: Living with fibromyalgia can feel like an uphill battle against chronic pain, affecting about 2% of Americans. Doctors often turn to antiepileptic drugs—specifically Pregabalin (Lyrica) and Gabapentin—to help dampen the pain signals. A recent review of eight medical studies shows that while these drugs do offer relief for many patients compared to a placebo, they aren't miracle cures. Roughly half of the patients experience significant pain reduction. However, the relief doesn't always last; in one long-term look, only about a third of patients felt the benefits after six months. Furthermore, side effects are common. While these medications are a helpful tool in the pain-management toolkit, they offer modest relief rather than a complete cure, and we still need more information on their long-term safety.